tiprankstipranks
Trending News
More News >
China Taiping Insurance Holdings Co Ltd (HK:0966)
:0966
Advertisement

China Taiping Insurance Holdings Co (0966) AI Stock Analysis

Compare
4 Followers

Top Page

HK:0966

China Taiping Insurance Holdings Co

(0966)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 4o)
Rating:71Outperform
Price Target:
HK$21.50
▲(14.91% Upside)
China Taiping Insurance Holdings Co's strong financial performance and attractive valuation are the most significant factors contributing to its overall score. The technical analysis indicates moderate momentum, supporting a positive outlook. The absence of earnings call data and corporate events does not impact the score.
Positive Factors
Revenue Growth
Consistent revenue growth indicates expanding market presence and effective sales strategies, supporting long-term business sustainability.
Cash Generation
Robust cash generation enhances liquidity and financial flexibility, enabling the company to invest in growth opportunities and manage obligations.
Financial Health
Improved leverage and financial health strengthen the company's balance sheet, reducing risk and supporting long-term operational stability.
Negative Factors
Equity Proportion
A low equity proportion may limit financial flexibility and increase vulnerability to market fluctuations, impacting long-term resilience.
EBIT Margin Anomaly
Anomalous EBIT margin figures suggest potential issues in cost management or reporting, which could affect profitability and investor confidence.
Equity Base Improvement
Limited equity base improvement may constrain growth potential and strategic investments, affecting long-term competitive positioning.

China Taiping Insurance Holdings Co (0966) vs. iShares MSCI Hong Kong ETF (EWH)

China Taiping Insurance Holdings Co Business Overview & Revenue Model

Company DescriptionChina Taiping Insurance Holdings Co., Ltd. is a leading insurance and financial services provider based in Hong Kong, with a strong presence in mainland China and other international markets. The company operates primarily through its subsidiaries in the insurance sector, offering a wide range of insurance products, including life insurance, property and casualty insurance, and health insurance. Additionally, the company is involved in asset management and investment services, positioning itself as a comprehensive financial services provider.
How the Company Makes MoneyChina Taiping Insurance generates revenue primarily through the sale of insurance premiums from its various insurance products, including life, health, and property insurance. The company collects premiums from policyholders, which form a significant portion of its income. Additionally, it earns investment income by investing the premiums received into various financial instruments, such as stocks, bonds, and real estate. The company also benefits from fee income generated from asset management services. Strategic partnerships with financial institutions and distribution channels enhance its reach, enabling China Taiping to expand its customer base and increase premium income.

China Taiping Insurance Holdings Co Financial Statement Overview

Summary
China Taiping Insurance Holdings Co demonstrates strong financial performance with significant revenue and profit growth, improved leverage, and effective cash flow management. The income statement reflects a positive growth trajectory, though the unusual EBIT margin requires further investigation. The balance sheet is stable, with room for improving the equity base.
Income Statement
78
Positive
The company shows strong revenue growth with a significant increase from 112.36 billion to 121 billion over the last year. Net profit margin improved from 4.78% to 6.97%, indicating better cost management. However, the EBIT margin fell from 17.72% to 100%, which requires further investigation as it seems unusual. Overall, the income statement reflects a positive growth trajectory with increasing profitability.
Balance Sheet
70
Positive
The balance sheet displays a stable debt-to-equity ratio, which decreased from 1.29 to 0.27, signifying improved leverage and financial health. The equity ratio stands at 5.02%, reflecting a low equity proportion, which is typical for insurance companies. Return on equity increased from 6.8% to 9.68%, indicating enhanced efficiency in generating profits from shareholders' equity. The balance sheet shows stability with some room for improving equity base.
Cash Flow
82
Very Positive
Operating cash flow remains strong and grew significantly from 134.6 billion to 125.95 billion. Free cash flow also shows a healthy growth rate, indicating robust cash generation capabilities. The operating cash flow to net income ratio is commendable, suggesting efficient cash conversion from earnings. The cash flow statement highlights strong liquidity and cash management practices.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue113.21B121.00B106.12B158.81B318.98B277.07B
Gross Profit113.21B121.00B123.32B104.86B316.11B271.14B
EBITDA18.59B26.91B19.85B12.65B16.45B17.50B
Net Income9.17B8.43B5.37B4.30B7.51B6.55B
Balance Sheet
Total Assets1.87T1.73T1.51T1.41T1.38T1.17T
Cash, Cash Equivalents and Short-Term Investments0.0044.39B42.55B308.46B293.80B266.36B
Total Debt33.28B82.12B101.43B117.05B95.17B61.27B
Total Liabilities1.74T1.61T1.38T1.31T1.27T1.05T
Stockholders Equity90.23B87.07B78.99B75.51B88.07B90.65B
Cash Flow
Free Cash Flow97.21B116.24B127.67B88.72B94.48B110.33B
Operating Cash Flow106.92B125.95B134.60B95.02B98.63B114.20B
Investing Cash Flow-158.04B-95.63B-130.95B-80.30B-99.62B-110.85B
Financing Cash Flow9.76B-27.91B19.79B-9.76B9.06B-945.65M

China Taiping Insurance Holdings Co Technical Analysis

Technical Analysis Sentiment
Positive
Last Price18.71
Price Trends
50DMA
17.28
Positive
100DMA
17.15
Positive
200DMA
14.70
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
57.05
Neutral
STOCH
52.06
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0966, the sentiment is Positive. The current price of 18.71 is above the 20-day moving average (MA) of 18.54, above the 50-day MA of 17.28, and above the 200-day MA of 14.70, indicating a bullish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 57.05 is Neutral, neither overbought nor oversold. The STOCH value of 52.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0966.

China Taiping Insurance Holdings Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
83
Outperform
HK$202.54B4.7234.37%5.92%49.90%203.77%
83
Outperform
$1.17T5.8928.10%3.44%17.69%126.41%
76
Outperform
$342.36B5.2218.41%3.53%15.08%23.13%
72
Outperform
$1.10T6.724.64%10.20%19.74%
72
Outperform
$844.19B18.4515.16%2.30%5.65%30.47%
71
Outperform
$65.16B7.9710.74%1.87%23.64%36.32%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0966
China Taiping Insurance Holdings Co
18.71
5.88
45.86%
HK:2318
Ping An Insurance Company of China
60.45
14.48
31.50%
HK:1299
AIA Group
78.30
21.66
38.24%
HK:2601
China Pacific Insurance (Group) Co
33.42
7.79
30.41%
HK:2628
China Life Insurance Co
28.22
12.61
80.83%
HK:1336
New China Life Insurance Co., Ltd. Class H
49.20
23.74
93.24%

China Taiping Insurance Holdings Co Corporate Events

China Taiping Announces Board Changes with New Director Appointment
Nov 21, 2025

China Taiping Insurance Holdings Co announced changes in its board of directors, with the resignation of non-executive directors Mr. Guo Zhaoxu and Ms. Zhang Cui due to retirement. Mr. Feng Zhanwu has been appointed as a new non-executive director and member of the risk management committee. The company expressed gratitude to the outgoing directors for their contributions and welcomed Mr. Feng to the board. This change is part of the company’s ongoing governance and leadership strategy, potentially impacting its strategic direction and stakeholder relations.

China Taiping Announces Board Composition and Committee Roles
Nov 21, 2025

China Taiping Insurance Holdings Co has announced the composition of its board of directors and their roles within various board committees. This announcement highlights the leadership structure and governance framework of the company, which is crucial for stakeholders to understand the decision-making processes and strategic direction of the company.

China Taiping Divests Minority Stakes in Strategic Transaction
Oct 31, 2025

China Taiping Insurance Holdings Co, through its non-wholly owned subsidiary TPL, has entered into agreements to transfer its minority equity interests in four subject companies, including CRCCI and CRCC Kunlun, to CRCC for a total cash consideration of RMB6.50 billion. This transaction marks a strategic move for TPL, as it divests its stakes in these companies, potentially impacting its investment portfolio and financial strategy. The agreements ensure that all profits and losses incurred by the subject companies between the signing and closing dates will be managed by CRCC, indicating a clear transfer of operational responsibilities.

China Taiping Reports Strong Q3 2025 Financial Performance
Oct 28, 2025

China Taiping Insurance Holdings Co has announced the unaudited financial figures and solvency statement of its subsidiaries for the third quarter of 2025. The announcement highlights the financial performance of its subsidiaries, including Taiping Life Insurance, Taiping General Insurance, and Taiping Reinsurance, which are regulated by the National Financial Regulatory Administration. The financial report reveals a net profit of RMB 1,813,042,000 and significant cash flows from operating activities, indicating strong operational performance. The disclosure is part of regulatory requirements for insurance companies with issued capital supplementary bonds, providing stakeholders with insights into the company’s financial health and compliance.

China Taiping Reports Strong Solvency Position in Q3 2025
Oct 28, 2025

China Taiping Insurance Holdings Co announced the release of its subsidiaries’ solvency report for the third quarter of 2025. The report highlights the financial health and regulatory compliance of its subsidiaries under the China Risk Oriented Solvency System Phase II. The figures, based on unaudited preliminary data, indicate a strong solvency position, with a comprehensive solvency ratio of 248% at the end of the quarter, reflecting the company’s robust capital management and financial stability.

China Taiping Insurance Appoints New Executive Director
Sep 25, 2025

China Taiping Insurance Holdings Co has announced the appointment of Ms. NA Yanfang as an executive director and a member of several key committees, effective September 25, 2025. This strategic move is expected to enhance the company’s governance and operational efficiency, potentially strengthening its position in the competitive insurance market.

China Taiping Insurance Announces Board Composition and Roles
Sep 25, 2025

China Taiping Insurance Holdings Co has announced the composition of its board of directors and their roles within the company. The board includes executive, non-executive, and independent non-executive directors, with specific members assigned to various committees such as Audit, Nomination and Remuneration, Risk Management, and Strategy and Investment. This announcement highlights the company’s governance structure, which is crucial for stakeholders to understand the leadership and decision-making processes within the organization.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 22, 2025